LINVATEC BELGIUM

Drogenbos ·KBO/BCE: BE 0471.726.242

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	nothing on record	not filed	-
31-12-2023	31-07-2024	25-11-2025	482 d late	2025-00571811
31-12-2022	31-07-2023	25-02-2025	575 d late	2025-00039233
31-12-2021	31-07-2022	09-11-2023	466 d late	2023-00511980
31-12-2020	31-07-2021	24-12-2021	146 d late	2021-81900091
31-12-2019	31-07-2020	30-11-2020	122 d late	2020-74100396
31-12-2018	31-07-2019	12-08-2019	12 d late	2019-45800254
31-12-2017	31-07-2018	06-08-2018	6 d late	2018-43800277
31-12-2016	31-07-2017	04-08-2017	4 d late	2017-41900299
31-12-2015	31-07-2016	29-06-2016	32 d early	2016-26200147
31-12-2014	31-07-2015	31-08-2015	31 d late	2015-56200247

Metric	This company	Sector median	Position in the sector
Solvency	99.7%	29.7%	better than 95% of 586 sector peers
Net result	€152k	€38k	better than 66% of 585 sector peers
Equity	€181.99M	€481k	better than 95% of 586 sector peers
Staff costs	€1.44M	€506k	higher than 71% of 441 sector peers
Employees (FTE)	2.0	7.5	better than 21% of 388 sector peers

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€182.58M
Fixed assets	21/28	€181.94M
Intangible fixed assets	21	€0
Tangible fixed assets	22/27	€3k
Financial fixed assets	28	€181.94M
Current assets	29/58	€636k
Stocks & contracts in progress	3	€0
Amounts receivable within one year	40/41	€508k
Cash & bank	54/58	€127k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€182.58M
Equity	10/15	€181.99M
Contributions / capital	10/11	€206.72M
Reserves	13	€20k
Accumulated profits (losses)	14	€-24.75M
Amounts payable	17/49	€587k
Amounts payable within one year	42/48	€557k
Trade debts payable within one year	44	€144k
Income statement
Operating result	9901	€90k
Financial income	75	€300k
Financial charges	65	€178k
Result before taxes	9903	€211k
Income taxes	67/77	€59k
Net result for the period	9904	€152k
Result to be appropriated	9905	€152k

Summary

Statutory auditor	IRE/IBR number	Tenure
GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISESCurrent Statutory auditor · represented by Gunther Loits	-	11-12-2015 → present
Grant Thornton, Bedrijfsrevisoren CVBA Company auditor · represented by Gunther Loits succeeded by GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES in 2015	-	25-04-2013 → 11-12-2015

NACE primary	Groothandel in farmaceutische en medische artikelen(46460)
Legal form	Public limited company(014)
Incorporation	18-04-2000
Status	Active
Postal code	1620